Acrongenomics Inc (AGNM) SEC Filing 8-K Material Event for the period ending Monday, September 3, 2007

Acrongenomics Inc

CIK: 1104502 Ticker: AGNM

View differences made from one to another to evaluate Acrongenomics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acrongenomics Inc.


Assess how Acrongenomics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acrongenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: AGNM
CIK: 1104502
Form Type: 8-K Corporate News
Accession Number: 0001085037-07-002197
Submitted to the SEC: Fri Sep 28 2007 12:28:58 PM EST
Accepted by the SEC: Fri Sep 28 2007
Period: Monday, September 3, 2007
Industry: Surgical And Medical Instruments And Apparatus
  1. Financial Exhibit
  2. New Agreement
  3. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: